300 related articles for article (PubMed ID: 23175790)
1. Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations.
Vargiu AV; Nikaido H
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20637-42. PubMed ID: 23175790
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors.
Vargiu AV; Ruggerone P; Opperman TJ; Nguyen ST; Nikaido H
Antimicrob Agents Chemother; 2014 Oct; 58(10):6224-34. PubMed ID: 25114133
[TBL] [Abstract][Full Text] [Related]
4. Molecular Interactions of Carbapenem Antibiotics with the Multidrug Efflux Transporter AcrB of
Atzori A; Malloci G; Cardamone F; Bosin A; Vargiu AV; Ruggerone P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013182
[TBL] [Abstract][Full Text] [Related]
5. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
[TBL] [Abstract][Full Text] [Related]
6. Unidirectional peristaltic movement in multisite drug binding pockets of AcrB from molecular dynamics simulations.
Feng Z; Hou T; Li Y
Mol Biosyst; 2012 Oct; 8(10):2699-709. PubMed ID: 22825052
[TBL] [Abstract][Full Text] [Related]
7. Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli.
Soparkar K; Kinana AD; Weeks JW; Morrison KD; Nikaido H; Misra R
J Bacteriol; 2015 Oct; 197(20):3255-64. PubMed ID: 26240069
[TBL] [Abstract][Full Text] [Related]
8. Substrate-dependent transport mechanism in AcrB of multidrug resistant bacteria.
Jewel Y; Van Dinh Q; Liu J; Dutta P
Proteins; 2020 Jul; 88(7):853-864. PubMed ID: 31998988
[TBL] [Abstract][Full Text] [Related]
9. Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB.
Kinana AD; Vargiu AV; Nikaido H
Biochemistry; 2013 Nov; 52(46):8342-51. PubMed ID: 24205856
[TBL] [Abstract][Full Text] [Related]
10. Molecular Interactions of Cephalosporins with the Deep Binding Pocket of the RND Transporter AcrB.
Atzori A; Malloci G; Prajapati JD; Basciu A; Bosin A; Kleinekathöfer U; Dreier J; Vargiu AV; Ruggerone P
J Phys Chem B; 2019 Jun; 123(22):4625-4635. PubMed ID: 31070373
[TBL] [Abstract][Full Text] [Related]
11. Perturbed structural dynamics underlie inhibition and altered efflux of the multidrug resistance pump AcrB.
Reading E; Ahdash Z; Fais C; Ricci V; Wang-Kan X; Grimsey E; Stone J; Malloci G; Lau AM; Findlay H; Konijnenberg A; Booth PJ; Ruggerone P; Vargiu AV; Piddock LJV; Politis A
Nat Commun; 2020 Nov; 11(1):5565. PubMed ID: 33149158
[TBL] [Abstract][Full Text] [Related]
12. Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump.
Kinana AD; Vargiu AV; May T; Nikaido H
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1405-10. PubMed ID: 26787896
[TBL] [Abstract][Full Text] [Related]
13. Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps.
Plé C; Tam HK; Vieira Da Cruz A; Compagne N; Jiménez-Castellanos JC; Müller RT; Pradel E; Foong WE; Malloci G; Ballée A; Kirchner MA; Moshfegh P; Herledan A; Herrmann A; Deprez B; Willand N; Vargiu AV; Pos KM; Flipo M; Hartkoorn RC
Nat Commun; 2022 Jan; 13(1):115. PubMed ID: 35013254
[TBL] [Abstract][Full Text] [Related]
14. Binding and Transport of Carboxylated Drugs by the Multidrug Transporter AcrB.
Tam HK; Malviya VN; Foong WE; Herrmann A; Malloci G; Ruggerone P; Vargiu AV; Pos KM
J Mol Biol; 2020 Feb; 432(4):861-877. PubMed ID: 31881208
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance.
Wang Y; Mowla R; Guo L; Ogunniyi AD; Rahman T; De Barros Lopes MA; Ma S; Venter H
Bioorg Med Chem Lett; 2017 Feb; 27(4):733-739. PubMed ID: 28129976
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance.
Mowla R; Wang Y; Ma S; Venter H
Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of carbapenem binding sites within the RND-transporter AcrB.
Atzori A; Malviya VN; Malloci G; Dreier J; Pos KM; Vargiu AV; Ruggerone P
Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):62-74. PubMed ID: 30416087
[TBL] [Abstract][Full Text] [Related]
18. Switch Loop Flexibility Affects Substrate Transport of the AcrB Efflux Pump.
Müller RT; Travers T; Cha HJ; Phillips JL; Gnanakaran S; Pos KM
J Mol Biol; 2017 Dec; 429(24):3863-3874. PubMed ID: 28987732
[TBL] [Abstract][Full Text] [Related]
19. Computer simulations suggest direct and stable tip to tip interaction between the outer membrane channel TolC and the isolated docking domain of the multidrug RND efflux transporter AcrB.
Schmidt TH; Raunest M; Fischer N; Reith D; Kandt C
Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1419-26. PubMed ID: 27045078
[TBL] [Abstract][Full Text] [Related]
20. Vestibules are part of the substrate path in the multidrug efflux transporter AcrB of Escherichia coli.
Husain F; Bikhchandani M; Nikaido H
J Bacteriol; 2011 Oct; 193(20):5847-9. PubMed ID: 21856849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
